Cathelicidin and PMB neutralize endotoxins by multifactorial mechanisms including LPS interaction and targeting of host cell membranes
Andra B. Schromm,Laura Paulowski,Yani Kaconis,Franziska Kopp,Max Koistinen,Annemarie Donoghue,Susanne Keese,Christian Nehls,Julia Wernecke,Patrick Garidel,Eva Sevcsik,Karl Lohner,Susana Sanchez-Gomez,Guillermo Martinez-de-Tejada,Klaus Brandenburg,Mario Brameshuber,Gerhard J. Schütz,Jörg Andrä,Thomas Gutsmann
DOI: https://doi.org/10.1073/pnas.2101721118
IF: 11.1
2021-06-28
Proceedings of the National Academy of Sciences
Abstract:Significance Antibiotic resistance among clinically relevant bacteria presents an increasing threat and raises the urgent need for new compounds. Antimicrobial peptides and peptide antibiotics are potent membrane-active molecules and valuable prototypes for drug development. In gram-negative infections, killing of bacteria by antimicrobials is accompanied by the release of lipopolysaccharide (LPS), an endotoxin that causes severe hyperinflammation and pathology. We demonstrate how two medically relevant peptides, the cathelicidin LL-32 and polymyxin B, disarm endotoxins by peptide–LPS interaction. Furthermore, our studies reveal a mechanism of peptide-mediated immune control by acting on signaling domains of the immune cell membrane. Our results significantly enhance our understanding of how peptide antibiotics can regulate inflammation and will be important for their development and therapeutic use.
multidisciplinary sciences